Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Braz. j. infect. dis ; 21(4): 418-423, July-Aug. 2017. tab
Artículo en Inglés | LILACS | ID: biblio-888896

RESUMEN

Abstract Introduction: The present study was designed to investigate the association between rs8177374 polymorphism and malaria symptoms due to exposure of Plasmodium vivax and Plasmodium falciparum. Materials and methods: A total of 454 samples were included in the study (228 malaria patients and 226 healthy individuals). Malaria patients, divided into P. vivax and P. falciparum groups on the basis of the causative species of Plasmodium, were categorized into mild and severe on the basis of clinical outcomes according to WHO criteria. Healthy individuals were used as controls. Allele specific PCR based strategy was used for the identification of rs8177374 SNP. Results: MyD88-adaptor-like gene polymorphism was associated with susceptibility to malaria (p < 0.001). C allele frequency (0.74) was higher in the population compared to T allele frequency (0.26). CT genotype increased the susceptibility of malaria (OR: 2.661; 95% CI: 1.722-4.113) and was positively associated with mild malaria (OR: 5.609; 95% CI: 3.479-9.044, p = 0.00). On the other hand, CC genotype was associated with severe malaria (OR: 3.116; 95% CI: 1.560-6.224, p = 0.00). P. vivax infection rate was higher in CT genotype carriers compared to other genotypes (OR: 3.616; 95% CI: 2.219-5.894, p < 0.001). Conclusion: MyD88-adaptor-like/TIR domain containing adaptor protein polymorphism for single nucleotide polymorphism rs8177374 is related with the susceptibility of malaria.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Glicoproteínas de Membrana/fisiología , Malaria Vivax/genética , Malaria Falciparum/genética , Receptores de Interleucina-1/fisiología , Predisposición Genética a la Enfermedad/genética , Polimorfismo de Nucleótido Simple , Pakistán , Índice de Severidad de la Enfermedad , Glicoproteínas de Membrana/genética , Estudios de Casos y Controles , Reacción en Cadena de la Polimerasa , Receptores de Interleucina-1/genética , Frecuencia de los Genes , Genotipo
2.
Mem. Inst. Oswaldo Cruz ; 108(6): 755-762, set. 2013. tab, graf
Artículo en Inglés | LILACS | ID: lil-685485

RESUMEN

Currently, several assays can confirm acute dengue infection at the point-of-care. However, none of these assays can predict the severity of the disease symptoms. A prognosis test that predicts the likelihood of a dengue patient to develop a severe form of the disease could permit more efficient patient triage and treatment. We hypothesise that mRNA expression of apoptosis and innate immune response-related genes will be differentially regulated during the early stages of dengue and might predict the clinical outcome. Aiming to identify biomarkers for dengue prognosis, we extracted mRNA from the peripheral blood mononuclear cells of mild and severe dengue patients during the febrile stage of the disease to measure the expression levels of selected genes by quantitative polymerase chain reaction. The selected candidate biomarkers were previously identified by our group as differentially expressed in microarray studies. We verified that the mRNA coding for CFD, MAGED1, PSMB9, PRDX4 and FCGR3B were differentially expressed between patients who developed clinical symptoms associated with the mild type of dengue and patients who showed clinical symptoms associated with severe dengue. We suggest that this gene expression panel could putatively serve as biomarkers for the clinical prognosis of dengue haemorrhagic fever.


Asunto(s)
Humanos , Antígenos de Neoplasias/genética , Cisteína Endopeptidasas/genética , Glicoproteínas de Membrana/genética , Proteínas de Neoplasias/genética , Peroxirredoxinas/genética , Receptores de IgG/genética , Receptores de Interleucina-1/genética , Índice de Severidad de la Enfermedad , Dengue Grave/diagnóstico , Proteínas Reguladoras de la Apoptosis/genética , Biomarcadores , Expresión Génica , Proteínas Ligadas a GPI/genética , Inmunidad Innata/genética , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/patología , Análisis por Micromatrices , Pronóstico , Reacción en Cadena en Tiempo Real de la Polimerasa , ARN Mensajero/aislamiento & purificación , Serotipificación
3.
Annals of Thoracic Medicine. 2012; 7 (2): 74-77
en Inglés | IMEMR | ID: emr-178345

RESUMEN

Multidrug-resistant Acinetobacter baumannii [MDRAB]-associated pneumonia has been a common disease and a therapeutic problem in hospitals. Interleukin-1 receptor antagonist [IL-1ra] has been considered a required role for host immune defense in pneumonia disease. The aim of this study was to investigate whether the variable nucleotide tandem repeat polymorphism of the IL-1ra gene was associated with MDRAB-related pneumonia. Sixty-six pneumonia patients were enrolled in the study: 36 subjects had MDRAB-related pneumonia and 30 controls had non-MDRAB pneumonia. Polymerase chain reaction, restriction fragment length polymorphism, and agarose gel electrophoresis techniques were used to determine the IL-1ra genotype. The frequencies of the IL-1ra genotype in the MDRAB-related pneumonia cases were A1/A1, 0.889 and A1/A2, 0.111; the frequencies of the IL-1ra genotype in the controls were A1/A1, 0.333 and A1/A2, 0.667. A statistically significant difference was determined [P < 0.05]. We also observed an increase in the frequency of IL-1ra A1 allele in the MDRAB-related pneumonia group. A statistically significant difference was determined [P<0.05]. We suggested that IL-1ra polymorphism was associated with the risk of MDRAB-related pneumonia


Asunto(s)
Humanos , Femenino , Masculino , Receptores de Interleucina-1/antagonistas & inhibidores , Polimorfismo Genético , Acinetobacter baumannii/efectos de los fármacos , Receptores de Interleucina-1/genética , Farmacorresistencia Microbiana , Neumonía
4.
Neurol India ; 2006 Dec; 54(4): 366-9
Artículo en Inglés | IMSEAR | ID: sea-121221

RESUMEN

BACKGROUND AND AIMS: Chronic inflammatory process plays an important role in atherothrombosis. Interleukin-1 (IL-1) is one of the key modulators of the inflammatory response and its activity is critically regulated by its receptor antagonist (IL-1Ra). A variable number tandem repeat polymorphism in intron 2 of IL-1Ra gene and a C to T single base polymorphism in the promoter of IL-1beta gene (C(-511)-->T) have been reported to affect the levels of IL-1 as well as its antagonist, IL-1Ra. It is also reported in several studies that these polymorphisms are associated with the susceptibility to cardio-cerebral vascular disease. However, data are limited in China. In this article, we studied the relationships between these polymorphisms and the risk of ischemic stroke in China. MATERIALS AND METHODS: One hundred and twelve patients committed ischemic stroke were compared with 95 demographically matched healthy volunteers. RESULTS: The frequencies of the IL-1Ra 1/1 genotype and IL-1Ra allele 1 (Ra*1 allele) in stroke patients were significantly higher than those in healthy volunteers [93.7% vs. 82.1%, P =0.014; 0.964 vs. 0.905, P =0.007]. No significant differences were found in the IL-1beta -511 genotype and the allele distribution between the two groups. CONCLUSIONS: Our results implicated that IL-1 gene polymorphism might be associated with the susceptibility to ischemic stroke.


Asunto(s)
Anciano , Isquemia Encefálica/complicaciones , China/epidemiología , Femenino , Frecuencia de los Genes , Humanos , Interleucina-1/genética , Interleucina-1beta/genética , Masculino , Persona de Mediana Edad , Familia de Multigenes/genética , Polimorfismo Genético/genética , Receptores de Interleucina-1/genética , Accidente Cerebrovascular/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA